- Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients
-
Imbrizi MR, Magro DO, Secundo TD, Cunha-Silva M, Kotze PG, Montes CG, Almeida JR, Cabral VL
- KMID: 2438444
- Intest Res.
- 2019 Jan;17(1):63-69.
- doi: 10.5217/ir.2018.00077
BACKGROUND/AIMS: Inflammatory bowel disease (IBD) are chronic entities characterized by local and systemic inflammation and may be associated with thrombosis. The aim of this study was to identify the prevalence... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn's disease
-
Kotze PG, Magro DO, Saab B, Saab MP, Pinheiro L, Olandoski , Ayrizono M, Martinez C, Coy CS
- KMID: 2402648
- Intest Res.
- 2018 Jan;16(1):62-68.
- doi: 10.5217/ir.2018.16.1.62
BACKGROUND/AIMS: The use of anti-tumor necrosis factor (anti-TNF) agents seems to reduce surgical rates and delay surgical procedures in prospective trials and population-based studies in the management of Crohn's disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease
-
Magro DO, Kotze PG, Martinez C, Camargo MG, Guadagnini D, Calixto AR, Vasques AC, Ayrizono M, Geloneze B, Pareja JC, Saad MJ, Coy CS
- KMID: 2382379
- Intest Res.
- 2017 Jul;15(3):352-357.
- doi: 10.5217/ir.2017.15.3.352
BACKGROUND/AIMS: Lipopolysaccharide (LPS) is a molecule formed by lipids and polysaccharides and is the major cell wall component of gram-negative bacteria. High LPS levels are known to block CD26 expression... -
- CITED
-
- Close
- SHARE
-
- Close
